<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
--------------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): July 12, 2000
NEXELL THERAPEUTICS INC.
(Exact name of registrant as specified in charter)
DELAWARE 0-19153 06-1192468
(State or other (Commission File Number) (IRS Employer
jurisdiction of Identification No.)
incorporation)
9 Parker, Irvine, CA 92618
(Address of principal executive offices) (Zip code)
Registrant's telephone number, including area code: (949) 470-9011
Not Applicable
(Former name or former address, if changed since last report)
Item 5. Other Events.
Attached hereto as Exhibit 99.1 is a copy of a press release issued by the
Registrant announcing certain management changes.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(a) Not applicable.
(b) Not applicable.
(c) Exhibits.
Exhibit Description
------- -----------
99.1 Press Release dated July 12, 2000 of the Registrant
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
NEXELL THERAPEUTICS INC.
(Registrant)
By: /s/ Richard L. Dunning
-----------------------------
Richard L. Dunning
Chairman of the Board and
Chief Executive Officer
Dated: July 18, 2000
2
<PAGE>
INDEX TO EXHIBITS
<TABLE>
<CAPTION>
Method of
Exhibit Description Filing
------- ----------- ---------
<S> <C> <C>
99.1 Press Release dated July 12, 2000 of the Registrant Filed herewith
electronically
</TABLE>
3
